Hims & Hers Health Inc (NYSE:HIMS) traded at $61.07 at close of the session on Friday, June 20 and made an upward move of 64.22% on its previous day’s price.
Looking at the stock we see that its previous close was $47.83 and the beta (5Y monthly) reads 2.097 with the day’s price range being $61.5201 – $64.6. The company has a trailing 12-month PE ratio of 93.48. In terms of its 52-week price range, HIMS has a high of $72.98 and a low of $13.47. The company’s stock has gained about 4.92% over that past 30 days.
Hims & Hers Health Inc has a market cap of $14.37 billion and is expected to release its quarterly earnings report on 2025-May-05.
On the other hand, looking at the outlook for the HIMS stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 13 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 5 have rated the Hims & Hers Health Inc (HIMS) stock as a Hold, while 7 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the HIMS stock currently stands at 2.70, and the current price level is 1637 off its SMA20 and 0.11 from its 50-day simple moving average. The beta value is 1576.76%, while the average true range (ATR) is currently pointing at 539.02%. The average price target for the stock over the next 12 months is $66.5, with the estimates having a low of $65 and a high of $68. These price ends are -6.44% and -11.35% off the current price level respectively, although investors could be excited at the prospect of a -8.89% if the HIMS share price touches on the median price of $66.5.
Coming back to Hims & Hers Health Inc (NYSE:HIMS), we note that the average 3-month trading volume was 1.07, while that of the preceding 10-day period stands at 35.96 million. Current shares outstanding are 215.21 million.
The insiders hold 10.43% of the company’s shares while institutions hold 70.32%. The data shows that short shares as of 2025-05-30, stood at 60.88 million at a short ratio of 1.15. This represents a 3378.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 62.31 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 165.92% up in year-to-date price movement.
